Panacea Biotec L posts Q4 net loss of Rs 18.31 cr
The company reported standalone net loss during the quarter stood at Rs 18.31 crore as compared to net loss of Rs 32.48 crore in the previous year quarter. Net revenue of the company rose substantially by 40.67 per cent at Rs 79.86 crore in January-March quarter of this fiscal as against Rs 56.77 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 15.85 per cent to Rs 95.97 crore from Rs 82.84 crore in year ago period. Other Income dipped by 72.12 per cent at Rs 7.75 crore versus (Mar'20 Rs 27.80 crore). Operating Profit slipped by 38.20 per cent to Rs -16.11 crore as against Rs -26.07 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 56.08 per cent in March quarter. Interest grew by 4.49 per cent y-o-y to Rs 1.86 crore, while Taxation decreased by 84.54 per cent at Rs 1.52 crore (Mar'20 Rs 9.83 crore).